Research services company IQVIA has unveiled new AI agents built using NVIDIA technology that are designed to enhance ...

Kite, unit today presented the latest results that demonstrate a 79% overall response rate (ORR) and 74% overall survival (OS ...

South Korea’s biosimilar drug developer Samsung Bioepis today presented the long-term safety data of Epysqli (eculizumab; ...

The US Food and Drug Administration (FDA) yesterday approved Nuvation Bio’s (NYSE: NUVB) Ibtrozi (taletrectinib), a kinase ...

French biotech Enterome has secured $19 million in private funding to accelerate development of its OncoMimics immunotherapy ...

California-based clinical-stage biotech Juvena Therapeutics has entered a global licensing and multi-target research ...

US biotech Novavax (Nasdaq: NVAX) has reported that its experimental combination COVID-19 and influenza vaccine generated ...

Biogen has highlighted the growing role of felzartamab in its pipeline during a virtual investor seminar, spotlighting three ...

Danish pharma major Novo Nordisk and privately-held Californian firm Deep Apple Therapeutics have announced a research ...

The UK’s medicines regulator has released a suite of new guidelines to steer companies through its upcoming decentralized ...

Switzerland-based Philochem and Bristol Myers Squibb (NYSE: BMY) radiopharma subsidiary RayzeBio have announced a definitive agreement under which Philochem will license the exclusive worldwide rights ...

US clinical-stage biotech Oncolytics Biotech today announced the appointment of Jared Kelly as chief executive (CEO) and a ...